Cholinergic Muscarinic Antagonist class drugs

5 results

  • Bevespi aerosphere

    (Glycopyrrolate and formoterol fumarate)
    AstraZeneca Pharmaceuticals LP
    Usage: BEVESPI AEROSPHERE is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It is not intended for the relief of acute bronchospasm or for asthma treatment.

  • Cobenfy

    (xanomeline and trospium chloride)
    E.R. Squibb & Sons, L.L.C.
    Usage: COBENFY is indicated for the treatment of schizophrenia in adults.

  • Cuvposa

    (glycopyrrolate)
    Merz Pharmaceuticals, LLC
    Usage: CUVPOSA is indicated for reducing chronic severe drooling in children aged 3 to 16 with neurologic conditions such as cerebral palsy.

  • Detrol la

    (tolterodine tartrate)
    Viatris Specialty LLC
    Usage: DETROL LA Capsules are indicated for treating overactive bladder symptoms, including urge urinary incontinence, urgency, and frequency.

  • Qbrexza

    (glycopyrronium)
    Journey Medical Corporation
    Usage: Qbrexza is indicated for the topical treatment of primary axillary hyperhidrosis in adults and pediatric patients aged 9 years and older.